For example, in prostate cancer, patients with ID1 up-regulation were found to be associated with a significant delay in developing biochemical relapse and ID1 overexpression could sensitize cells to docetaxel-induced cytotoxicity13. This evidence concerns the gene ID1 and prostate cancer.